Pure Global AI
NCT05865964Recruiting

Anthropological, Socio-cultural and Psychological Surgeons' Factors in Oncology and Brakes for Evaluation of Innovations

Evaluation of Anthropological, Socio-cultural and Psychological Factors of Surgeons Practising in Oncology Which Condition Brakes in the Evaluation of Surgical Innovations
Institut Claudius RegaudClinicalTrials.gov
Verified
Study focus
Disease/Condition
Surgery
Study type
Observational
Sponsor & location
Primary sponsor
Institut Claudius Regaud
Location
Toulouse, France
Timeline & enrollment
Phase
N/A
Start date
Dec 14, 2022
End date
Dec 13, 2024
Enrollment
200 participants
Primary outcome

Identification of the parameters associated with barriers to the evaluation of surgical innovations.

Summary

The field of surgery continues to benefit from innovative solutions, changing surgical
 methods and techniques. Evaluation in terms of efficacy and Quality-Safety is an essential
 topic that directly affects the introduction of innovations. It is essential to carry out a
 robust evaluation strategy for surgical innovations, even if these are often opposed to drug
 innovations. The aim of this study is to investigate the anthropological, socio-cultural and
 psychological differences of surgeons that influence the evaluation of surgical innovations.

ICD-10 classifications
Other surgical proceduresSurgical procedure, unspecifiedDuring surgical operationDuring surgical operationDuring surgical operation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05865964
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05865964 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut Claudius Regaud and is currently Recruiting. The study focuses on Surgery. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.